SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...

Using cells from kidney biopsies, Johns Hopkins Medicine, researchers report progress in the search for more accurate and easier-to-obtain markers to help predict, manage and assess treatment of acute ...

Doctors around the world have different views on diagnosing kidney diseases and on when a biopsy is needed to give a clearer ...

How would you summarize your study for a lay audience? Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer. However, they can cause a wide ...